Rifamate (sanofi-aventis U.S. LLC)


Welcome to the PulseAid listing for the Rifamate drug offered from sanofi-aventis U.S. LLC. This Rifamycin Antibacterial [EPC],Rifamycins [Chemical/Ingredient],Antimycobacterial [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: sanofi-aventis U.S. LLC
NON-PROPRIETARY NAME: rifampin and isoniazid
SUBSTANCE NAME: RIFAMPIN; ISONIAZID
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Rifamycin Antibacterial [EPC],Rifamycins [Chemical/Ingredient],Antimycobacterial [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 1975-07-11
END MARKETING DATE: 0000-00-00


Rifamate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionRifamate from sanofi-aventis U.S. LLC
LABELER NAME: sanofi-aventis U.S. LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 300; 150(mg/1; mg/1)
START MARKETING DATE: 1975-07-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0068-0509_414a7294-4fe1-442b-bf2b-5825d83991d2
PRODUCT NDC: 0068-0509
APPLICATION NUMBER: ANDA061884

Other RIFAMPIN; ISONIAZID Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
sanofi-aventis U.S. LLCRifamate
VersaPharm IncorporatedIsonaRif